Tekturna HCT
Links shared publicly online about this topic
Tekturna HCT approved for first-line hypertension therapy - MPR
empr.com — “The FDA has approved an expanded indication for Tekturna HCT (aliskiren/hydrochlorothiazide tablets, from Novartis) to include initial therapy for patients with hypertension who are likely to need multiple drugs to achieve their blood pressure goals.” View full resource at empr.com
Most Recently Shared on July 21, 2009 at 3:42 pm By:
MPR News: Tekturna HCT approved for first-line hypertension therapy: The FDA has approved an expanded i.. http://bit.ly/LHzN
TEKTURNA HCT 150/12.5 (Aliskiren, Hydrochlorothiazide) drug information from MPR
empr.com — “TEKTURNA HCT 150/12.5 (Aliskiren, Hydrochlorothiazide) drug information for Hypertension from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on October 22, 2009 at 6:36 am By:
MPR News: TEKTURNA HCT 150/12.5: Adults: added initial therapy. http://bit.ly/qbzDP
FDA approves Tekturna HCT as initial treatment in patients unlikely to achieve their blood pressure goal with a single agent
novartis.com — “Basel, July 21, 2009 - The US Food and Drug Administration (FDA) has approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tekturna HCT is a single-pill combination of Tekturna (aliskiren), the first and only approved direct renin inhibitor[1], and the diuretic hydrochlorothiazide (HCTZ), one of the most commonly used high blood pressure medications[5].” View full resource at novartis.com
Most Recently Shared on July 21, 2009 at 1:43 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Tekturna HCT® as initial treatment in pts unlikely to achieve blood pressure goal with a single agent http://bit.ly/AfNcA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Advertisement
